HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Once-Weekly shot shows promise for Long-Term hypoparathyroidism control
Disease control OngoingThis study looks at the long-term safety of an experimental drug called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. About 60 adults who finished a 12-week phase 2 study will receive weekly injections of MBX 2…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New registry tracks Real-World outcomes for hypoparathyroidism treatment
Knowledge-focused OngoingThis study is a registry that collects information from over 1,300 people with chronic hypoparathyroidism to see how well the drug rhPTH(1-84) works and how safe it is over time in everyday medical practice. Participants receive their usual care and fill out questionnaires during…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC